Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$409,509
+$17,095 QoQ
Shares Held
2,613
+1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#981
of 1,603 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONECO ADVISORS, LLC holds $43,364,399 across 12 Drug Manufacturers - General names. NVS ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,501 | $16,381,318 | |
| 2 | LLY |
ELI LILLY & Co
|
6,143 | $7,368,099 | |
| 3 | ABBV |
AbbVie Inc.
|
22,944 | $5,773,628 | |
| 4 | PFE |
Pfizer Inc
|
170,546 | $4,106,747 | |
| 5 | GSK |
GSK plc
|
60,767 | $3,185,406 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,894 | $2,427,879 | |
| 7 | AMGN |
Amgen Inc
|
4,401 | $1,593,690 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
11,852 | $682,912 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $409,509 | 2,613 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $392,414 | 2,569 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $360,392 | 2,614 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $335,219 | 2,614 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $318,861 | 2,635 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $290,182 | 2,603 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $212,441 | 1,847 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $216,859 | 2,037 | Shares | Sole | 2024-07-19 | |
| 2023-12-31 | $211,532 | 2,095 | Shares | Sole | 2024-03-13 | |
| 2023-09-30 | $217,878 | 2,139 | Shares | Sole | 2024-03-13 | |
| 2023-06-30 | $215,644 | 2,137 | Shares | Sole | 2024-03-13 | |
| No filing history on record for this holder in this stock. | ||||||